Irma Bagdoniene: Multidisciplinary Management of High-Risk Familial Hypercholesterolaemia and CAD
Irma Bagdoniene, Cardiologist Specializing in Prevention and Lipidology, shared a post on LinkedIn:
“Story from the Lipid Clinic Part 2
Remember the patient with vague chest symptoms, an untreated LDL-C of 234 mg/dL, elevated Lp(a), and a coronary CT showing extensive coronary atherosclerosis?
Her story continued. Because of the pathological CT findings and her exertional symptoms, she underwent invasive coronary angiography.
- The proximal LAD showed an 80 percent stenosis. Physiological assessment confirmed its relevance: iFR 0.85–0.86.
- The RCA showed significant disease as well, including a 90% distal stenosis. FFR was 0.78, confirming functionally relevant ischemia.
Both vessels were successfully treated with PCI and drug-eluting stents. What started with years of high LDL cholesterol and rather unspecific symptoms had become established, intervention-requiring two-vessel coronary artery disease.
But for me, this case is about much more than finding stenoses and placing stents. It shows what can happen when the different pieces of cardiovascular medicine come together.
Prevention recognised the risk: high lifetime LDL exposure, family history and symptoms that could easily have been dismissed as nonspecific.
Lipidology raised the suspicion of familial hypercholesterolaemia and identified markedly elevated Lp(a).
Cardiac imaging made the burden of coronary atherosclerosis visible.
Coronary physiology with iFR and FFR showed which lesions were functionally significant. Interventional cardiology successfully treated the relevant coronary lesions.
And now the story returns to secondary prevention: intensive LDL lowering, antiplatelet therapy and management of every modifiable cardiovascular risk factor. Her LDL-C target is now 40 mg/dL , and her lipid-lowering therapy will be intensified accordingly.
Teamwork! It takes a village…
Prevention. Lipidology. Cardiac imaging. Coronary physiology. Interventional cardiology. Nursing. Follow-up. And, most importantly, the patient herself.
Did we prevent a future myocardial infarction? We will never know. Now begins the long-term task of keeping her cardiovascular risk as low as possible.
To be continued…
P.S. what raised my suspicion even further was this small carotid plaque – almost as if the vessels were trying to tell us something before the coronary CT did.
And a very special thanks to my favourite team player in the cath lab: Dr. med. Mohammad Al Mawed.”

Stay updated with Hemostasis Today.
-
Nov 20, 2026, 17:27Adam Bryant: Great Science, Valuable Connections and a Wonderful Haematology Community at Blood 2026
-
Nov 20, 2026, 17:25Gurpreet Kaurr: Scientific Discussions, New Perspectives and Inspiration at HAEMATOCON 2026
-
Nov 20, 2026, 17:24Bispecific FVIIIa-Mimetic Antibodies in Haemophilia A – CRH French Reference Center for Hemophilia Lyon
-
Nov 20, 2026, 17:23Khalid Rehman: Psychosocial Burden Among Caregivers of Patients with Beta-Thalassemia Major in Pakistan
-
Nov 20, 2026, 17:20Dhinesh Selvaraju: Caplacizumab Becomes the First FDA-Approved Treatment for Pediatric aTTP
-
Nov 20, 2026, 17:19Paris Margaritis: Presenting Preclinical Data on GENV-HEM at the WFH Workshop
-
Nov 20, 2026, 17:18WFH Opens Public Comment on Draft Guidelines for Hemostatic Agents and Prophylaxis
-
Nov 20, 2026, 17:18Ketan Asawale: Consensus on the Management of Cancer-Associated Thrombosis in India
-
Nov 20, 2026, 17:16Ajay Samkaria: The Evolution of Hemostasis Diagnostics with the ACL TOP 70 Series